CClinicalTrials.gg
CompletedNCT02303691Updated Mar 8, 2018

Attention Bias Modification for Transdiagnostic Anxiety

An interventional study of Attention Bias Modification and Neutral Training in Anxiety and Anxiety Disorders, sponsored by University of Pittsburgh. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2018-03-08.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

This project seeks to identify neural mechanisms underlying the tendency for anxious individuals to pay more attention to threatening information than to other types of information. A computerized treatment designed to train individuals to reduce their attention towards threat will be tested, with a focus on understanding the aspects of brain function that predict response to the treatment. This work could ultimately lead to the ability to treat anxiety more effectively by directly targeting the aspects of brain function that are altered in a given patient.

02

Conditions studied

  • Anxiety
  • Anxiety Disorders

Browse trials for

Keywords

  • anxiety
  • attention bias modification
  • computer
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 70 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,385 studies on the registry; 167 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participants will:

    1. be between the ages of 18 and 55 years,
    2. score >45 on the Spielberger State-Trait Anxiety Inventory-trait form.
    3. score >=75th percentile on the World Health Organization Disability Assessment Schedule 2.0

Exclusion criteria

Exclusion Criteria:

  1. Current medication or Cognitive-Behavioral Therapy for anxiety or depression;
  2. Failure to meet standard Magnetic Resonance Imaging (MRI) inclusion criteria: those who have cardiac pacemakers, neural pacemakers, surgical clips in the brain or blood vessels, surgically implanted metal plates, screws or pins, cochlear implants, Intrauterine Devices, metal braces, or other metal objects in their body, especially in the eye. If the subject has any metal or implants in the body they must be deemed safe by the MRI Research Center's safety screening procedure prior to enrollment. Dental fillings do not present a problem. Plastic or removable dental appliances do not require exclusion. Pregnancy, determined by pregnancy tests on females.
  3. currently suicidal or at risk for harm to self or others,
  4. visual disturbance (\<20/40 as per the Snellen test, corrective lenses allowed)
  5. \<6th grade reading level as per the Wide Range Achievement Test
  6. presence of bipolar, psychotic, autism spectrum, substance dependence, or primary depressive disorder
  7. positive urine drug test
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Computerized Attention Bias Modification

    Behavioral: Attention Bias Modification

  • Sham comparator
    Computerized Neutral Training

    Behavioral: Neutral Training

Interventions

  • BehavioralAttention Bias Modification

    Excessive attention to threat is theorized to be a critical contributor to chronic anxiety symptoms and related negative health consequences. Attention Bias Modification, which directly targets this mechanism, is a highly cost-effective intervention with growing empirical support for its potential efficacy in clinically anxious populations.

  • BehavioralNeutral Training

    A control version of computerized attention training.

06

What researchers measure

Primary outcomes

  1. CAPS--Hypervigilance item

    Time frame: 1 month

Secondary outcomes

  1. Mood and Anxiety Symptoms Questionnaire

    Time frame: 1 month

  2. Mini International Neuropsychiatric Interview (MINI)

    Time frame: 1 month

  3. Attentional bias towards threat (Performance-based assessment of attentional bias towards threat based on reaction times and eye tracking)

    Performance-based assessment of attentional bias towards threat based on reaction times and eye tracking

    Time frame: immediate

  4. Penn State Worry Questionnaire

    Time frame: 1 month

  5. Liebowitz Social Anxiety Scale

    Time frame: 1 month

  6. World Health Organization Disability Assessment Scale (WHODAS)

    Time frame: 1 month

  7. Speilberger State-Trait Anxiety Inventory

    Time frame: 1 month

  8. Beck Anxiety Inventory

    Time frame: 1 month

Other outcomes

  1. Functional Magnetic Resonance Imaging

    (collected post-treatment in subsample of active arm only)

    Time frame: 1 month

  2. Pupillometry

    Time frame: 1 month

07

Study locations

1 site
  • University of Pittsburgh Department of Psychiatry
    Pittsburgh, Pennsylvania 15213, United States
08

References and documents

Publications

  • Price RB, Cummings L, Gilchrist D, Graur S, Banihashemi L, Kuo SS, Siegle GJ. Towards personalized, brain-based behavioral intervention for transdiagnostic anxiety: Transient neural responses to negative images predict outcomes following a targeted computer-based intervention. J Consult Clin Psychol. 2018 Dec;86(12):1031-1045. doi: 10.1037/ccp0000309. PubMed 30507228 ↗
  • Price RB, Brown V, Siegle GJ. Computational Modeling Applied to the Dot-Probe Task Yields Improved Reliability and Mechanistic Insights. Biol Psychiatry. 2019 Apr 1;85(7):606-612. doi: 10.1016/j.biopsych.2018.09.022. Epub 2018 Oct 5. PubMed 30449531 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 8, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02303691
Lead sponsor
University of Pittsburgh
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Rebecca Price (PhD, University of Pittsburgh) — Principal investigator
First posted
Dec 1, 2014
Start date
Apr 2013
Primary completion
Jan 2017
Completion
Jan 2018
Last update
Mar 8, 2018

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion